SPP1 and cancer: Hormone therapy was not perfect: Wang et al. (2023) discovered that androgen deprivation therapy (ADT), including GnRHas, induced SPP1+ myofibroblastic cancer-associated fibroblasts (myCAFs), which proved to be crucial stromal constituents that drove the development of castration-resistant prostate cancer (CRPC).